The power of specialty palliative care: moving towards a systems perspective

Lancet Haematol. 2021 May;8(5):e376-e381. doi: 10.1016/S2352-3026(21)00099-5.

Abstract

Three palliative care clinical trials were presented at the 2020 American Society for Clinical Oncology Annual Meeting. The heterogeneity in populations, models of care, study design, and assessment of clinical outcomes across these three studies show the broad opportunities for research into interventions for palliative care. In this Viewpoint, we summarise the characteristics of these studies, discuss their novel features and lingering questions, and offer a suggestion for further expanding the focus of clinical trials for delivery of palliative care in the future. We particularly argue that the propensity to characterise palliative care as if it was a clinical or biomedical intervention hampers the design and evaluation of complex clinical interventions that influence clinicians, systems for health-care delivery, individual patients, and their families.

Publication types

  • Review

MeSH terms

  • Adaptation, Psychological
  • Antineoplastic Agents / therapeutic use
  • Clinical Trials as Topic
  • Family / psychology
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / psychology
  • Palliative Care*
  • Quality of Life

Substances

  • Antineoplastic Agents